Bioinformatics approaches identified dasatinib and bortezomib inhibit the activity of MCM7 protein as a potential treatment against human cancer

Minichromosome Maintenance Complex Component 7 (MCM7) is a key component of the DNA replication licensing factor and hexamer MCM (MCM2–7) complex that regulates the DNA replication process. The MCM7 protein is associated with tumor cell proliferation that plays an important role in different human c...

Descripción completa

Detalles Bibliográficos
Autores principales: Samad, Abdus, Huq, Md. Amdadul, Rahman, Md. Shahedur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795118/
https://www.ncbi.nlm.nih.gov/pubmed/35087187
http://dx.doi.org/10.1038/s41598-022-05621-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795118/
https://www.ncbi.nlm.nih.gov/pubmed/35087187
http://dx.doi.org/10.1038/s41598-022-05621-0

Ejemplares similares